These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 17230421)
1. Influence of consecutive-day blood sampling on polymerase chain reaction-adjusted parasitological cure rates in an antimalarial-drug trial conducted in Tanzania. Martensson A; Ngasala B; Ursing J; Isabel Veiga M; Wiklund L; Membi C; Montgomery SM; Premji Z; Farnert A; Bjorkman A J Infect Dis; 2007 Feb; 195(4):597-601. PubMed ID: 17230421 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania. Mårtensson A; Strömberg J; Sisowath C; Msellem MI; Gil JP; Montgomery SM; Olliaro P; Ali AS; Björkman A Clin Infect Dis; 2005 Oct; 41(8):1079-86. PubMed ID: 16163624 [TBL] [Abstract][Full Text] [Related]
3. Molecular genotyping to distinguish between recrudescents and new infections in treatment trials of Plasmodium falciparum malaria conducted in Sub-Saharan Africa: adjustment of parasitological outcomes and assessment of genotyping effectiveness. Mugittu K; Adjuik M; Snounou G; Ntoumi F; Taylor W; Mshinda H; Olliaro P; Beck HP Trop Med Int Health; 2006 Sep; 11(9):1350-9. PubMed ID: 16930256 [TBL] [Abstract][Full Text] [Related]
4. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso. Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228 [TBL] [Abstract][Full Text] [Related]
5. Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study: comparison of results based on genotyping of msp-1, msp-2, and glurp. Cattamanchi A; Kyabayinze D; Hubbard A; Rosenthal PJ; Dorsey G Am J Trop Med Hyg; 2003 Feb; 68(2):133-9. PubMed ID: 12641400 [TBL] [Abstract][Full Text] [Related]
6. Comparison of sulfadoxine-pyrimethamine, unsupervised artemether-lumefantrine, and unsupervised artesunate-amodiaquine fixed-dose formulation for uncomplicated plasmodium falciparum malaria in Benin: a randomized effectiveness noninferiority trial. Faucher JF; Aubouy A; Adeothy A; Cottrell G; Doritchamou J; Gourmel B; Houzé P; Kossou H; Amedome H; Massougbodji A; Cot M; Deloron P J Infect Dis; 2009 Jul; 200(1):57-65. PubMed ID: 19469703 [TBL] [Abstract][Full Text] [Related]
7. Comparison of artemether-lumefantrine with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in eastern Nepal. Thapa S; Hollander J; Linehan M; Cox-Singh J; Bista MB; Thakur GD; Davis WA; Davis TM Am J Trop Med Hyg; 2007 Sep; 77(3):423-30. PubMed ID: 17827354 [TBL] [Abstract][Full Text] [Related]
8. A comparative study on the efficacy of artesunate plus sulphadoxine/pyrimethamine versus artemether-lumefantrine in eastern Sudan. Mukhtar EA; Gadalla NB; El-Zaki SE; Mukhtar I; Mansour FA; Babiker A; El-Sayed BB Malar J; 2007 Jul; 6():92. PubMed ID: 17631681 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of sulfadoxine-pyrimethamine in the treatment of uncomplicated Plasmodium falciparum malaria in East Timor. Burns M; Baker J; Auliff AM; Gatton ML; Edstein MD; Cheng Q Am J Trop Med Hyg; 2006 Mar; 74(3):361-6. PubMed ID: 16525092 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of sulfadoxine-pyrimethamine in Tanzania after two years as first-line drug for uncomplicated malaria: assessment protocol and implication for treatment policy strategies. Mugittu K; Abdulla S; Falk N; Masanja H; Felger I; Mshinda H; Beck HP; Genton B Malar J; 2005 Nov; 4():55. PubMed ID: 16297234 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy and effects of artemether-lumefantrine and amodiaquine-sulfalene-pyrimethamine on gametocyte carriage in children with uncomplicated Plasmodium falciparum malaria in southwestern Nigeria. Sowunmi A; Gbotosho GO; Happi CT; Adedeji AA; Fehintola FA; Folarin OA; Tambo E; Fateye BA Am J Trop Med Hyg; 2007 Aug; 77(2):235-41. PubMed ID: 17690392 [TBL] [Abstract][Full Text] [Related]
12. Molecular genotyping in a malaria treatment trial in Uganda - unexpected high rate of new infections within 2 weeks after treatment. Mugittu K; Priotto G; Guthmann JP; Kiguli J; Adjuik M; Snounou G; Beck HP; Mshinda H; Olliaro PL; Taylor WR Trop Med Int Health; 2007 Feb; 12(2):219-23. PubMed ID: 17300628 [TBL] [Abstract][Full Text] [Related]
13. Plasmodium falciparum population dynamics during the early phase of anti-malarial drug treatment in Tanzanian children with acute uncomplicated malaria. Carlsson AM; Ngasala BE; Dahlström S; Membi C; Veiga IM; Rombo L; Abdulla S; Premji Z; Gil JP; Björkman A; Mårtensson A Malar J; 2011 Dec; 10():380. PubMed ID: 22185672 [TBL] [Abstract][Full Text] [Related]
14. Artemether-Lumefantrin (Coartem) and artesunate with sulfadoxine-pyrimethamine therapeutic efficacy in the treatment of uncomplicated malaria at Gilgel Gibe II (GGII) South-Western Ethiopia. Seboxa T; Mao P; Pinchouk N; Anbessie J; Alemu H; Diro E Ethiop Med J; 2010 Oct; 48(4):285-91. PubMed ID: 21280430 [TBL] [Abstract][Full Text] [Related]
15. Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria. Barnes KI; Little F; Mabuza A; Mngomezulu N; Govere J; Durrheim D; Roper C; Watkins B; White NJ J Infect Dis; 2008 Jun; 197(11):1605-13. PubMed ID: 18471066 [TBL] [Abstract][Full Text] [Related]
16. Adherence and efficacy of supervised versus non-supervised treatment with artemether/lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Bangladesh: a randomised controlled trial. Rahman MM; Dondorp AM; Day NP; Lindegardh N; Imwong M; Faiz MA; Bangali AM; Kamal AT; Karim J; Kaewkungwal J; Singhasivanon P Trans R Soc Trop Med Hyg; 2008 Sep; 102(9):861-7. PubMed ID: 18606428 [TBL] [Abstract][Full Text] [Related]
17. Antimalarial resistance and DHFR/DHPS genotypes of Plasmodium falciparum three years after introduction of sulfadoxine-pyrimethamine and amodiaquine in rural Tanzania. Eriksen J; Mwankusye S; Mduma S; Veiga MI; Kitua A; Tomson G; Petzold MG; Swedberg G; Gustafsson LL; Warsame M Trans R Soc Trop Med Hyg; 2008 Feb; 102(2):137-42. PubMed ID: 18082233 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Bangladesh. Haque R; Thriemer K; Wang Z; Sato K; Wagatsuma Y; Salam MA; Akther S; Akter J; Fukuda M; Miller RS; Noedl H Am J Trop Med Hyg; 2007 Jan; 76(1):39-41. PubMed ID: 17255226 [TBL] [Abstract][Full Text] [Related]
19. A randomized trial of artesunate-mefloquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali. Sagara I; Diallo A; Kone M; Coulibaly M; Diawara SI; Guindo O; Maiga H; Niambele MB; Sissoko M; Dicko A; Djimde A; Doumbo OK Am J Trop Med Hyg; 2008 Nov; 79(5):655-61. PubMed ID: 18981499 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia. Denis MB; Tsuyuoka R; Lim P; Lindegardh N; Yi P; Top SN; Socheat D; Fandeur T; Annerberg A; Christophel EM; Ringwald P Trop Med Int Health; 2006 Dec; 11(12):1800-7. PubMed ID: 17176344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]